New EDS & HSD Diagnostic Criteria Are Coming December 1, 2026 — What This Means for You

The Ehlers-Danlos Society just made an announcement that our entire community has been waiting years for — and at Hypermobility Hub, we want to make sure you hear it directly, clearly, and without the overwhelm.

For the first time since 2017, the diagnostic criteria for ALL types of Ehlers-Danlos Syndromes (EDS) and Hypermobility Spectrum Disorders (HSD) are being updated.

The new framework will be published on December 1, 2026, in the American Journal of Medical Genetics — one of the leading peer-reviewed journals in genetic and rare disease research worldwide. Then in March 2027, a second publication will follow with best-practice care and management pathways to guide providers in supporting patients after diagnosis.

This initiative — known as the Road to 2026 — represents years of international research collaboration, systematic literature review, Delphi consensus methodology, rigorous peer review, and importantly, the inclusion of lived experience at every step of the process. Source: The Ehlers-Danlos Society

Let's Talk About the Anxiety — Because It's Real

If your first reaction to this news was a knot in your stomach, you are not alone. Many people in our community have spent years — sometimes decades — fighting to receive their EDS or HSD diagnosis. The fear that a criteria update could somehow invalidate your journey is understandable. It deserves to be named directly.

Here is what I want you to hold onto:

The goal of this update is to reduce diagnostic delays, improve access to care pathways, and better reflect the actual multisystem, episodic reality of living with EDS and HSD. This is science working for our community, not against it. The Ehlers-Danlos Society has committed that when December 1st arrives, they will provide explanations, guides, and community support to help navigate every change.

At Hypermobility Hub, we are making that same commitment to you. We will be following this closely, collaborating through the EDS ECHO provider network, and translating every update into clear, actionable, patient-centered language. You will not walk through this alone.

What We Know So Far

  • 📅 December 1, 2026 — New diagnostic criteria framework published in American Journal of Medical Genetics

  • 📋 March 2027 — Best-practice care and management pathways published

  • 🌍 Scope — Covers ALL types of EDS and HSD, not just hEDS

  • 🔬 Methodology — International collaboration, Delphi consensus, systematic literature review, peer review, and lived experience integration

  • 🏛️ Led by — Independent global experts, funded and facilitated by The Ehlers-Danlos Society

Introducing the Hypermobility Hub Pattern Recognition Model

One thing I've been thinking about deeply as this moment approaches is this: even the best diagnostic criteria can only capture a snapshot in time. And EDS doesn't live in a snapshot. It lives across years of your health story — in the patterns of your flares, your triggers, your test results, your wearable data, your specialist notes scattered across a dozen different systems.

That's exactly why I've been developing what I call the Hypermobility Hub Pattern Recognition Model — a five-pillar clinical framework specifically designed for the episodic, multisystem nature of connective tissue and autonomic disorders.

The five pillars are:

  1. Comprehensive Clinical Evaluation — detailed history, multisystem exam, imaging and lab review

  2. Longitudinal Symptom Pattern Identification — patient-tracked timing, triggers, and severity over time

  3. Patient-Owned Health Records — your complete medical history, portable across every system you've touched

  4. Physiologic Monitoring & Digital Health Technologies — wearables, heart rate variability, orthostatic data

  5. Collaborative Multidisciplinary Care — neurology, cardiology, rheumatology, PM&R, pain, and beyond

I'm currently working toward peer-reviewed publication of this framework — and I believe that implementing this model alongside the new diagnostic criteria arriving in December could represent a genuinely transformative moment for how we diagnose and care for people with EDS and HSD.

I'll be sharing much more about this model in upcoming videos and posts. Subscribe to our YouTube channel and follow along — because this conversation is just getting started.

What Hypermobility Hub Is Doing Right Now

✅ Actively monitoring Road to 2026 updates through the EDS ECHO network ✅ Preparing patient education resources for the December 1st release ✅ Developing clinical implementation guidance for the Pattern Recognition Model ✅ Building out our Flare Management and Pattern Recognition content series

Watch the Full Video

https://www.youtube.com/@HypermobilityHub

Have Questions?

If you have concerns about how the upcoming criteria changes may affect your care, diagnosis, or treatment plan — reach out. That is exactly what Hypermobility Hub is here for.

👉 Request an Appointment 📧 info@hypermobilityhub.com 📞 (904) 674-8037

Crystal Wade, MSN, APRN, AGACNP-BC is the Founder & CEO of Hypermobility Hub, a specialty clinical practice in Jacksonville, FL. She is a board-certified Adult-Gerontology Acute Care Nurse Practitioner and EDS ECHO member specializing in Ehlers-Danlos Syndrome, hypermobility spectrum disorders, and connective tissue conditions.

Next
Next

Turning the Page: New Beginnings as a Nurse Practitioner.